GENB news

Latest 1 stories · newest Nov 12, 2026

GENB

Generate Announces Q3 2026 Results & Business Update

Generate Biomedicines announced strong financial results and clinical progress across its programs, including the potential shift to twice-a-year dosing for its severe asthma candidate GB-0895.

Earnings Nov 12, 2026 sentiment +0.60 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same GENB feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/GENB/newsSTART FREE